NeuroSense Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NRSN and other ETFs, options, and stocks.About NRSN
Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company, which engages n the discovery and development of targeted therapeutics for neurodegenerative diseases. The firm offers PrimeC, a therapy for amyotrophic lateral sclerosis (ALS).
CEOAlon Ben-Noon
CEOAlon Ben-Noon
Employees15
Employees15
HeadquartersHerzliya, Tel Aviv
HeadquartersHerzliya, Tel Aviv
Founded2017
Founded2017
Employees15
Employees15
NRSN Key Statistics
Market cap34.43M
Market cap34.43M
Price-Earnings ratio-2.00
Price-Earnings ratio-2.00
Dividend yield—
Dividend yield—
Average volume362.91K
Average volume362.91K
High today$1.23
High today$1.23
Low today$1.10
Low today$1.10
Open price$1.21
Open price$1.21
Volume282.85K
Volume282.85K
52 Week high$2.60
52 Week high$2.60
52 Week low$0.81
52 Week low$0.81
Stock Snapshot
The current NeuroSense Therapeutics(NRSN) stock price is $1.11, with a market capitalization of 34.43M. The stock trades at a price-to-earnings (P/E) ratio of -2.00.
On 2025-12-06, NeuroSense Therapeutics(NRSN) stock traded between a low of $1.10 and a high of $1.23. Shares are currently priced at $1.11, which is +1.2% above the low and -9.5% below the high.
The NeuroSense Therapeutics(NRSN)'s current trading volume is 282.85K, compared to an average daily volume of 362.91K.
During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.81 at its lowest and $2.60 at its peak.
During the past year, NeuroSense Therapeutics(NRSN) stock moved between $0.81 at its lowest and $2.60 at its peak.
People also own
Based on the portfolios of people who own NRSN. This list is generated using Robinhood data, and it’s not a recommendation.